Skip to main content
Log in

Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Intracellular catabolism of NAD in mammalian cells occurs mainly via reaction catalyzed by poly(ADP-ribose) polymerase (PARP) with the release of nicotinamide, which is then metabolized predominantly to N-methyl-2-pyridone-5-carboxamide (2PY). PARP could be activated by binding to broken DNA and is known to be involved in DNA repair mechanisms, cell stress response and regulation of apoptosis. 2PY may accumulate under disease conditions resulting in accelerated DNA damage and retention of catabolic products. Our hypothesis was that chronic renal failure would lead to elevation of 2PY and potentially to inhibition of PARP and related physiological mechanisms. In the present study we: (a) compared plasma 2PY concentration in healthy subjects and in patients with chronic renal failure (CRF); (b) evaluated the relationship between plasma 2PY concentration and the severity of CRF; (c) evaluated the effect of hemodialysis treatment and kidney transplantation on 2PY concentration.

We found that the plasma 2PY concentration in healthy subjects is 0.83 ± 0.18 μM but it could increase up to 40 μM in patients with CRF. A significant correlation was found in CRF between plasma 2PY and creatinine concentration. A single hemodialysis treatment was associated with significant reduction of plasma 2PY concentration after the hemodialysis, but it increased rapidly 48 h after the end of treatment. Successful kidney transplantation was associated with return of 2PY concentration to the normal range.

In conclusion, our results indicated significant production of 2PY in humans. In healthy subjects 2PY is cleared from the plasma by excretion in the urine. Altered excretion by the kidney leads to increase in plasma concentration of 2PY. It is possible that 2PY may play a significant role in the development of uremic toxemia, especially as an inhibitor of poly(ADP-ribose)polymerase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stratford MR, Dennis MF: High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine. J Chromatogr 582: 145–151, 1992

    Google Scholar 

  2. Shibata K, Toda S: Effects of sex hormones on the metabolism of tryptophan to niacin and to serotonin in male rats. Biosci Biotechnol Biochem 61: 1200–1202, 1997

    Google Scholar 

  3. D'Amours D, Desnoyers S, S'silva I, Poirier GG: Poly(ADP-ribosyl) reactions in the regulation of nuclear functions. Biochem J 342: 249–268, 1999

    Google Scholar 

  4. Jacobson MK, Jacobson EL: Discovering new ADP-ribose polymer cycles: protecting the genome and more. Trends Biochem Sci 24: 415–417, 1999

    Google Scholar 

  5. Devlin TM: In: Textbook of Biochemistry with Clinical Correlations. Wiley-Liss, Inc., New York, 1992, pp 561–562

    Google Scholar 

  6. Smith S: The world according to PARP. Trends in Biochem Sci 26: 174–179, 2001

    Google Scholar 

  7. Goodwin POM, Lewis PJ, Davies MI, Skidmore CJ, Shall S: The effect of gamma radiation and neocarzinostatin on NAD and ATP levels in mouse leukemia cells Biochim Biophys Acta 543: 576–582, 1978

    Google Scholar 

  8. Skidmore CJ, Davies MI, Goodwin PM, Halldorson H, Lewis PJ, Shall S, Zia'ee AA: The involvement of poly(ADP-ribose)polymerase in the degradation of NAD caused by gamma radiation and N-methyl-Nnitrosourea. Eur J Biochem 101: 135–142, 1979

    Google Scholar 

  9. Yamanaka H, Penning CA, Wullis EH, Wasson DB, Carson DA: Characterization of human poly(ADP-ribose)polymerase with autoantibodies. J Biol Chem 263: 3879–3883, 1988

    Google Scholar 

  10. Ludwig A, Behnke B, Holtlund J, Hilz H: Immunoquantitaion and size determination of intrinsic poly(ADP-ribose)polymerase from acid precipitates. Analysis of the in vivo status in mammalian species and in lower eukaryotes. J Biol Chem 263: 6993–6999, 1988

    Google Scholar 

  11. Shieh WM, Ame JC, Wilson MV, Wang ZQ, Koh DW, Jacobson MK, Jacobson EL: Poly(ADP-ribose)polymerase null mouse cells synthesis ADP-ribose polymers. J Biol Chem 273: 30069–30072, 1998

    Google Scholar 

  12. Gillmor HA, Bolton CH, Hopton M, Moore WPT, Perrett D, Bingley PJ, Gale EAM: Measurement of nicotinamide and N-methyl-2-pyridone-5-carboxamide in plasma by high performance liquid chromatography. Biomed Chromatogr 13: 360–362, 1999

    Google Scholar 

  13. Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH: Effect of vitamin E-bonded membrane on the 8-hydroxy-2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 58: 790–799, 2000

    Google Scholar 

  14. Tarng DC, Huang TP, Wei YH, Liu TY, Chen HW, Wen Chen T, Yang WC: 8-hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 36: 934–944, 2000

    Google Scholar 

  15. Marlewski M, Smolenski RT, Szolkiewicz M, Aleksandrowicz Z, Rutkowski B, Swierczynski J: Increased rate of adenine incorporation into adenine nucleotide pool in erythrocytes of patients with chronic renal failure. Nephron 86: 281–286, 2000

    Google Scholar 

  16. Smolenski RT, Lachno DR, Ledingham SJM, Yacoub MH: Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr 527: 414–420, 1990

    Google Scholar 

  17. Menissier-de Murcia J, Molinete M, Gradwohl G, Simonin F, de Murcia G: Zinc-binding domain of poly(ADP-ribose)polymerase participates in the recognition of single strand breaks on DNA. J Mol Biol 210: 229–233, 1989

    Google Scholar 

  18. Benjamin RC, Gill DM: ADP-ribosylation in mammalian cell ghosts. Dependence of poly (ADP-ribose) synthesis on strand breakage in DNA. J Biol Chem 255: 10493–10501, 1980

    Google Scholar 

  19. Pieper AA, Verna A, Zhang J, Snyder SH: Poly(ADP-ribose)-polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20: 171–181, 1999

    Google Scholar 

  20. Pieper AA, Walles T, Wei G, Clements EE, Verna A, Snyder SH, Zweier JL: Myocardial postischemic injury is reduced by poly(ADPribose) polymerase-1 gene disruption. Mol Med 6: 271–282, 2000

    Google Scholar 

  21. Zhang J, Pieper AA, Snyder SH: Poly(ADP-ribose) synthetase activation: An early indicator of neurotoxic DNA damage. J Neurochem 65: 1411–1414, 1995

    Google Scholar 

  22. Rut A, de Murcia G, Schulz GE: Inhibitor and NAD+ binding to poly(ADP-ribose)polymerase as derived from crystal structures and homology modeling. Biochemistry 37: 3893–3900, 1998

    Google Scholar 

  23. Virag L, Szabo C: Purines inhibit poly(ADP-ribose)polymerase activation and modulate oxidant-induced cell death. FASEB J 15: 99–107, 2001

    Google Scholar 

  24. Althans FR, Richter C: ADP-ribosylation of proteins. Enzymology and biological significance. Mol Biol Biochem Biophys 37: 1–237, 1987

    Google Scholar 

  25. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney APS, Briggs D, McCredie M, Boyle P: Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 354: 93–99, 1999

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Slominska, E.M., Smolenski, R.T., Szolkiewicz, M. et al. Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure. Mol Cell Biochem 231, 83–88 (2002). https://doi.org/10.1023/A:1014445329756

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014445329756

Navigation